外涂盐酸倍他洛尔滴眼液治疗7例表浅型婴幼儿血管瘤疗效观察

doi:10.19438/j.cjoms.2017.05.013

中国口腔颌面外科杂志 ›› 2017, Vol. 15 ›› Issue (5): 438-441.doi: 10.19438/j.cjoms.2017.05.013

外涂盐酸倍他洛尔滴眼液治疗7例表浅型婴幼儿血管瘤疗效观察

周昱川，凌彬，龚忠诚，许颖捷，陈青立

新疆医科大学第一附属医院口腔医学中心颌面肿瘤外科，新疆乌鲁木齐 830054

收稿日期:2017-01-04 出版日期:2017-08-30 发布日期:2017-10-27
通讯作者: 龚忠诚，E-mail：565249755@qq.com
作者简介:周昱川（1989-），女，在读硕士研究生，E-mail：843806258@qq.com

Treatment of 7 superficial infantile hemangiomas with betaxolol hydrochloride eye drops

ZHOU Yu-chuan, LING Bin, GONG Zhong-cheng, XU Ying-jie, CHEN Qing-li.

Oncology Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Xinjiang Medical University, Stomatology School of Xinjiang Medical University. Urumqi 830054, Xinjiang Autonomous Region, China

Received:2017-01-04 Online:2017-08-30 Published:2017-10-27

摘要/Abstract

摘要： 目的：探讨局部外用盐酸倍他洛尔滴眼液治疗表浅型婴幼儿血管瘤的临床疗效及安全性。方法：选择7 例表浅型婴幼儿血管瘤患者，其中男3例，女4例，年龄30~156 d，平均年龄97 d。在瘤体表面外涂盐酸倍他洛尔滴眼液，年龄大于2个月的患儿每天外涂5次，年龄不足2个月的患儿每天外涂3次。分别记录用药前、后的瘤体颜色、大小、张力、厚度等变化，同时观察用药后不良反应，评估用药安全性。结果：治疗后，7例患儿的瘤体均不同程度地面积缩小、质地变软及颜色消退，所有患儿均未出现可检测到的不良反应。结论：外涂盐酸倍他洛尔滴眼液能有效促进血管瘤消退，且未发现不良反应，有望作为治疗婴幼儿血管瘤一种有效的辅助治疗方法。

关键词: 婴幼儿血管瘤, 盐酸倍他洛尔滴眼液, β受体阻滞剂

Abstract: PURPOSE: To explore the clinical efficacy and safety of betaxolol hydrochloride eye drops treatment for superficial infantile hemangiomas. METHODS: Among 31 cases with superficial infantile hemangiomas, 7 patients (3 males and 4 females) with superficial infantile hemangiomas were selected　according to inclusion criteria, their age ranged from 30 days to 156 days, with an average age of 97 days. Betaxolol hydrochloride eye drops were applied on the tumor surface, 5 times per day in children older than 2 months, and 3 times per day in children less than 2 months. The changes of color, size, tension and thickness were recorded before and after treatment, and adverse reactions were observed in order to evaluate the safety of the treatment. RESULTS: After treatment, 7 patients had varying degrees of reduction and softened texture, the lesion color faded, no adverse reactions were noted. CONCLUSIONS: Betaxolol hydrochloride eye drops might be one of the effective ways to treat superficial infantile hemangiomas with less adverse reaction.

Key words: Infantile ｈemangiomas, Betaxolol hydrochloride eye drops, β-adrenergic receptor blocker

中图分类号:

R782.2

周昱川，凌彬，龚忠诚，许颖捷，陈青立. 外涂盐酸倍他洛尔滴眼液治疗7例表浅型婴幼儿血管瘤疗效观察[J]. 中国口腔颌面外科杂志, 2017, 15(5): 438-441.

ZHOU Yu-chuan, LING Bin, GONG Zhong-cheng, XU Ying-jie, CHEN Qing-li.. Treatment of 7 superficial infantile hemangiomas with betaxolol hydrochloride eye drops[J]. China J Oral Maxillofac Surg, 2017, 15(5): 438-441.

参考文献

[1] Shah S, Frieden IJ. Treatment of infantile hemangiomas with beta-blockers: a review [J]. Skin Ther Letter, 2013, 18(6): 5-7.
[2] Chakkittakandiyil A, Phillips R, Frieden IJ, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study [J]. Pediatr Dermatol, 2012, 29(1): 28-31.
[3] Tong S, Xu DP, Liu ZM, et al. Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas [J]. Oncol Lett, 2016, 12(3): 1806-1810.
[4] 郑家伟. 婴幼儿血管瘤"等待观察"的治疗策略应予改变 [J].中国口腔颌面外科杂志, 2012, 10(2):163-164.
[5] Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy [J]. N Engl J Med, 2008, 358(24): 2649-2651.
[6] 中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形诊断和治疗指南(2016版) [J]. 组织工程与重建外科杂志, 2016, 12(2): 63-93.
[7] López-Sendón J, Swedberg K, McMurray J, et al. Expert consensus document on beta-adrenergic receptor blockers [J]. Eur Heart J, 2004, 25(15): 1341-1362.
[8] 诸骏仁, 桑国卫. 中华人民共和国药典临床用药须知. 化学药和生物制品卷(2005年版) [M]. 北京: 人民卫生出版社, 2005: 181-184.
[9] Kaplan NM. Kaplan's clinical hypertension [M]. 8th Ed. Ｎｅｗ　Ｙｏｒｋ: Lippincott Williams & Wilkins, 2002: 261-268.
[10] Weber MA. The role of the new beta-blockers in treating cardiovascular disease [J]. Am J Hypertens, 2006, 18(12 Pt 2): 169S-176S.
[11] Lindholm LH, Carlberg B, Samuelsson O. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis [J]. Lancet, 2005, 366(9496): 1545-1553.
[12] 赵连友, 孙宁玲, 孙英贤, 等. α/β受体阻滞剂在高血压治疗中应用的中国专家共识[J].中华高血压杂志, 2016, 24(6): 521-526.
[13] Zhang Q, Chantasart D, Li SK. Evaluation of β-blocker gel and effect of dosing volume for topical delivery [J]. J Pharm Sci, 2015, 104(5): 1721-1731.
[14] Chantasart D, Hao J, Li SK. Evaluation of skin permeation of β-blockers for topical drug delivery [J]. Pharm Res, 2014, 30(3): 866-877.
[15] Australia-New Zealand Heart Failure Research Collaborative Group. Randomized, placebo-controlled trial of carvedilol with congestive heart failure due to ischemic heart disease [J]. Lancet, 1997, 349(9049): 375-380.

外涂盐酸倍他洛尔滴眼液治疗7例表浅型婴幼儿血管瘤疗效观察

Treatment of 7 superficial infantile hemangiomas with betaxolol hydrochloride eye drops

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李晓, 范新东, 郑家伟. 脉管异常的ISSVA分类概要及分子生物学研究进展[J]. 中国口腔颌面外科杂志, 2023, 21(3): 286-290.
[2]	郑家伟, 王绪凯, 秦中平, 范新东, 李凯, 杨耀武, 霍然, 刘少华, 赵吉宏, 汪小勇, 周德凯, 刘学键. 口服普萘洛尔治疗婴幼儿血管瘤中国专家共识（2022版）[J]. 中国口腔颌面外科杂志, 2022, 20(4): 313-319.
[3]	郑家伟, 赵泽亮, 陈启铭. 婴幼儿血管瘤循证治疗现状[J]. 中国口腔颌面外科杂志, 2022, 20(1): 7-14.
[4]	王杞章, 郑家伟. 口服普萘洛尔治疗婴幼儿增殖期血管瘤:英国儿科皮肤病学会共识及临床指南[J]. 中国口腔颌面外科杂志, 2020, 18(6): 548-552.
[5]	顾达, 霍然, 徐广琪, 毕见海, 李尚滨. 局部外用β受体阻滞剂治疗婴幼儿血管瘤的临床应用研究进展[J]. 中国口腔颌面外科杂志, 2020, 18(4): 375-380.
[6]	李红, 周昱川, 龚忠诚, 孙杨, 凌彬. 口服普萘洛尔联合外用盐酸倍他洛尔治疗8例眶周高风险婴幼儿血管瘤的疗效和安全性评价[J]. 中国口腔颌面外科杂志, 2020, 18(3): 264-268.
[7]	宋会新, 林春男, 王田友, 付兆臣. 普萘洛尔治疗婴幼儿血管瘤的作用机制研究进展[J]. 中国口腔颌面外科杂志, 2020, 18(2): 182-185.
[8]	刘学键, 刘志鹏, 武宜雷, 邰茂众. 平阳霉素新剂型瘤体内注射治疗婴幼儿血管瘤203例临床分析[J]. 中国口腔颌面外科杂志, 2019, 17(3): 247-250.
[9]	张凯驰, 徐大朋, 程沫沙, 王绪凯. 马来酸噻吗洛尔和普萘洛尔治疗婴幼儿表浅型血管瘤的疗效分析[J]. 中国口腔颌面外科杂志, 2017, 15(6): 529-533.
[10]	程沫沙，张凯驰，王绪凯. 普萘洛尔治疗溃疡性婴幼儿血管瘤18例临床分析[J]. 中国口腔颌面外科杂志, 2017, 15(3): 264-267.
[11]	王菲楠, 范新东. 放射性核素治疗婴幼儿血管瘤的现状[J]. 中国口腔颌面外科杂志, 2016, 14(5): 471-474.
[12]	彭昊，周国瑜，赵建鑫，沈玲悦，马川. 组织块法建立婴幼儿血管瘤动物模型的实验研究[J]. 中国口腔颌面外科杂志, 2015, 13(6): 486-490.
[13]	王亚飞, 周权, 王忠强. 小剂量盐酸普萘洛尔口服治疗不同月龄婴幼儿血管瘤临床疗效观察[J]. 中国口腔颌面外科杂志, 2015, 13(1): 38-41.
[14]	王佳, 石静, 王绪凯. 0.5%马来酸噻吗洛尔溶液联合普萘洛尔治疗婴幼儿血管瘤的不良反应观察[J]. 中国口腔颌面外科杂志, 2014, 12(6): 539-542.
[15]	郑家伟, 马坤宁, 张凌. 婴幼儿血管瘤药物治疗概述[J]. 中国口腔颌面外科杂志, 2014, 12(1): 1-6.